Literature DB >> 18926666

Symptom remission in first episode patients.

Jean Addington1, Donald Addington.   

Abstract

Recently, new remission criteria for schizophrenia has been proposed, based on low symptom severity of core symptoms (the severity criteria), which is sustained over a minimum of 6 months (time criterion). The purpose of this study was to examine, in a secondary analysis, these criteria in a cohort of 240 first episode patients with a mean follow-up of 26.4 months from the Calgary Early Psychosis Program. Eighty-eight subjects (36.7%) met both the severity criteria and time criteria for remission (in-remission group); 47 subjects (19.6%) met only the severity criteria at their most recent assessment (severity only group); 49 (20.4%) subjects had met severity criteria at one or more assessments but did not meet severity or severity and time at the most recent assessment (fluctuating group); and 56 (23.3%) did not meet remission criteria (non-remission group). Those who achieved remission had lower levels of symptoms and higher functioning at baseline and at the final follow-up assessment, improved premorbid functioning, shorter duration of untreated psychosis and increased changes in symptoms over time.

Entities:  

Mesh:

Year:  2008        PMID: 18926666     DOI: 10.1016/j.schres.2008.09.014

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  13 in total

1.  Evaluation of a multi-element treatment center for early psychosis in the United States.

Authors:  Sarah R Uzenoff; David L Penn; Karen A Graham; Sylvia Saade; Barbara B Smith; Diana O Perkins
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-01-26       Impact factor: 4.328

Review 2.  Progress in defining optimal treatment outcome in schizophrenia.

Authors:  Gary Remington; George Foussias; Ofer Agid
Journal:  CNS Drugs       Date:  2010-01       Impact factor: 5.749

3.  Symptomatic Remission in Schizophrenia and its Relationship with Functional Outcome Measures in Indian Population.

Authors:  Selvaraj Madhivanan; Komal Jayaraman; Sharon Joe Daniel; Jeyaprakash Ramasamy
Journal:  J Clin Diagn Res       Date:  2017-01-01

4.  Rates and predictors of 18-months remission in an epidemiological cohort of 661 patients with first-episode psychosis.

Authors:  Philippe Conus; Sue Cotton; Benno G Schimmelmann; Patrick D McGorry; Martin Lambert
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-05-05       Impact factor: 4.328

5.  Prediction of Early Symptom Remission in Two Independent Samples of First-Episode Psychosis Patients Using Machine Learning.

Authors:  Rigas F Soldatos; Micah Cearns; Mette Ø Nielsen; Costas Kollias; Lida-Alkisti Xenaki; Pentagiotissa Stefanatou; Irene Ralli; Stefanos Dimitrakopoulos; Alex Hatzimanolis; Ioannis Kosteletos; Ilias I Vlachos; Mirjana Selakovic; Stefania Foteli; Nikolaos Nianiakas; Leonidas Mantonakis; Theoni F Triantafyllou; Aggeliki Ntigridaki; Vanessa Ermiliou; Marina Voulgaraki; Evaggelia Psarra; Mikkel E Sørensen; Kirsten B Bojesen; Karen Tangmose; Anne M Sigvard; Karen S Ambrosen; Toni Meritt; Warda Syeda; Birte Y Glenthøj; Nikolaos Koutsouleris; Christos Pantelis; Bjørn H Ebdrup; Nikos Stefanis
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

6.  Is poor premorbid functioning a risk factor for suicide attempts in first-admission psychosis?

Authors:  Shelly Bakst; Jonathan Rabinowitz; Evelyn J Bromet
Journal:  Schizophr Res       Date:  2009-12-01       Impact factor: 4.939

Review 7.  Schizophrenia outcomes in the 21st century: A systematic review.

Authors:  Peter Huxley; Anne Krayer; Rob Poole; Louise Prendergast; Sanjaya Aryal; Richard Warner
Journal:  Brain Behav       Date:  2021-05-15       Impact factor: 2.708

Review 8.  Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later.

Authors:  Martin Lambert; Anne Karow; Stefan Leucht; Benno G Schimmelmann; Dieter Naber
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

Review 9.  Clinical predictors of therapeutic response to antipsychotics in schizophrenia.

Authors:  Maren Carbon; Christoph U Correll
Journal:  Dialogues Clin Neurosci       Date:  2014-12       Impact factor: 5.986

10.  Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study.

Authors:  Virginia S Haynes; Baojin Zhu; Virginia L Stauffer; Bruce J Kinon; Michael D Stensland; Lei Xu; Haya Ascher-Svanum
Journal:  BMC Psychiatry       Date:  2012-12-05       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.